Eastling Thomas Wilson 4
4 · GYRE THERAPEUTICS, INC. · Filed Nov 1, 2023
Insider Transaction Report
Form 4
Eastling Thomas Wilson
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-10-31+314,652→ 314,652 totalExercise: $6.93Exp: 2033-10-31→ Common Stock (314,652 underlying) - Award
Stock Option (Right to Buy)
2023-10-31+1,866→ 1,866 totalExercise: $6.93Exp: 2033-10-31→ Common Stock (1,866 underlying)
Footnotes (2)
- [F1]These options are vested in full.
- [F2]These options vest as to one-third on each of the first, second and third anniversaries of October 31, 2023, subject to the Reporting Person's continued service to the Issuer through each vesting date.